📰 Seth Wander News
Seth Wander News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Seth Wander. Real-time updates on events, politics, business and more.
April 19, 2024
COLUMBUS, Ohio, April 19, 2024 (GLOBE NEWSWIRE) -- Sermonix Pharmaceuticals Inc., a privately held biopharmaceutical company developing innovative therapeutics to specifically treat metastatic breast cancers (mBC)
January 6, 2024
Seth Wander, MD, PhD, discusses findings from an analysis of baseline genomic alterations in patients with estrogen receptor–positive, HER2-negative metastatic breast cancer who were enrolled in the single-arm, phase 2 ELAINE-2 trial of lasofoxifene plus abemaciclib.
January 4, 2024
Durable responses with lasofoxifene plus abemaciclib in post-CDK4/6 inhibitor setting
December 8, 2023
/PRNewswire/ -- Regor Therapeutics Group ("Regor"), a global innovator powered by cutting-edge drug discovery engine and differentiated clinical development...
October 9, 2023
Oncology experts discuss the platinum chemotherapy shortage in the United States.
October 4, 2023
Seth Wander, MD, PhD, discusses the evaluation of vepdegestrant (ARV-471), a proteolysis targeting chimera estrogen receptor degrader, in patients with advanced estrogen receptor/HER2-negative breast cancer.